Roswell Park Glioblastoma Vaccine Misses Main Survival Goal, but Patients 65 and Younger Lived Longer in Unpublished Data

SurVaxM missed its main survival goal in glioblastoma but helped patients 65 and younger in early data. What families should know about the vaccine.

Have A Referral?